The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
An Eighteen‐Membered Macrocyclic Ligand for Actinium‐225 Targeted Alpha Therapy
Abstract
The 18‐membered macrocycle H 2 macropa was investigated for 225 Ac chelation in targeted alpha therapy (TAT). Radiolabeling studies showed that macropa, at submicromolar concentration, complexed all 225 Ac (26 kBq) in 5 min at RT. [ 225 Ac(macropa)] + remained intact over 7 to 8 days when challenged with either excess La 3+ ions or human serum, and did not accumulate in any organ after 5 h in healthy mice. A bifunctional analogue, macropa‐NCS, was conjugated to trastuzumab as well as to the prostate‐specific membrane antigen‐targeting compound RPS‐070. Both constructs rapidly radiolabeled 225 Ac in just minutes at RT, and macropa‐Tmab retained >99 % of its 225 Ac in human serum after 7 days. In LNCaP xenograft mice, 225 Ac‐macropa‐RPS‐070 was selectively targeted to tumors and did not release free 225 Ac over 96 h. These findings establish macropa to be a highly promising ligand for 225 Ac chelation that will facilitate the clinical development of 225 Ac TAT for the treatment of soft‐tissue metastases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shannon, R. D. (1976) · Acta Crystallographica Section A · doi:10.1107/s0567739476001551 · Cited by 66,145
Moasser, M. M. (2007) · Oncogene · doi:10.1038/sj.onc.1210477 · Cited by 1,219
Matching chelators to radiometals for radiopharmaceuticals
Price, E. W., & Orvig, C. (2014) · Chem. Soc. Rev. · doi:10.1039/c3cs60304k · Cited by 1,018
Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer
Ghosh, A., & Heston, W. D. W. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10661 · Cited by 878
Albumin Binding as a General Strategy for Improving the Pharmacokinetics of Proteins
Dennis, M. S., Zhang, M., Meng, Y. G., Kadkhodayan, M., Kirchhofer, D., Combs, D., & Damico, L. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205854200 · Cited by 508
Tumor therapy with targeted atomic nanogenerators.
McDevitt, M. R., Ma, D., Lai, L. T., Simon, J., Borchardt, P., Frank, R. K., Wu, K., Pellegrini, V., Curcio, M. J., Miederer, M., et al. (2001) · Science · doi:10.1126/science.1064126 · Cited by 501
Hillier, S. M., Maresca, K. P., Femia, F. J., Marquis, J. C., Foss, C. A., Nguyen, N., Zimmerman, C. N., Barrett, J. A., Eckelman, W. C., Pomper, M. G., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1682 · Cited by 316
Self-citationMaresca, K. P., Hillier, S. M., Femia, F. J., Keith, D., Barone, C., Joyal, J. L., Zimmerman, C. N., Kozikowski, A. P., Barrett, J. A., Eckelman, W. C., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm800994j · Cited by 295
Self-citationLeyland-Jones, B., Gelmon, K., Ayoub, J.-P., Arnold, A., Verma, S., Dias, R., & Ghahramani, P. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.12.109 · Cited by 293
An overview of targeted alpha therapy
Kim, Y.-S., & Brechbiel, M. W. (2012) · Tumor Biology · doi:10.1007/s13277-011-0286-y · Cited by 278
A Portable Albumin Binder from a DNA‐Encoded Chemical Library
Dumelin, C. E., Trüssel, S., Buller, F., Trachsel, E., Bootz, F., Zhang, Y., Mannocci, L., Beck, S. C., Drumea‐Mirancea, M., Seeliger, M. W., et al. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200704936 · Cited by 233
Design and synthesis of 225Ac radioimmunopharmaceuticals.
McDevitt, M. R., Ma, D., Simon, J., Frank, R. K., & Scheinberg, D. A. (2002) · Applied Radiation and Isotopes · doi:10.1016/s0969-8043(02)00167-7 · Cited by 225
Miederer, M., Scheinberg, D. A., & McDevitt, M. R. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.04.009 · Cited by 210
First-in-Man Evaluation of 2 High-Affinity PSMA-Avid Small Molecules for Imaging Prostate Cancer
Barrett, J. A., Coleman, R. E., Goldsmith, S. J., Vallabhajosula, S., Petry, N. A., Cho, S., Armor, T., Stubbs, J. B., Maresca, K. P., Stabin, M. G., et al. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.111203 · Cited by 208
Self-citationActinium-225 in targeted alpha-particle therapeutic applications.
A. Scheinberg, D., & R. McDevitt, M. (2011) · Current Radiopharmaceuticalse · doi:10.2174/1874471011104040306 · Cited by 176
Dekempeneer, Y., Keyaerts, M., Krasniqi, A., Puttemans, J., Muyldermans, S., Lahoutte, T., D’huyvetter, M., & Devoogdt, N. (2016) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2016.1185412 · Cited by 171
Miederer, M., Henriksen, G., Alke, A., Mossbrugger, I., Quintanilla-Martinez, L., Senekowitsch-Schmidtke, R., & Essler, M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4647 · Cited by 155
Improved in Vivo Stability of Actinium-225 Macrocyclic Complexes
Deal, K. A., Davis, I. A., Mirzadeh, S., Kennel, S. J., & Brechbiel, M. W. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990141f · Cited by 130
Harrison, M. R., George, D. J., Wong, & Armstrong, A. J. (2013) · Cancer Management and Research · doi:10.2147/cmar.s25537 · Cited by 117
Comparison of 225actinium chelates: tissue distribution and radiotoxicity
Davis, I. A., Glowienka, K. A., Boll, R. A., Deal, K. A., Brechbiel, M. W., Stabin, M. G., Bochsler, P. N., Mirzadeh, S., & Kennel, S. J. (1999) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(99)00024-4 · Cited by 105
Aqueous Complexes for Efficient Size-based Separation of Americium from Curium
Jensen, M. P., Chiarizia, R., Shkrob, I. A., Ulicki, J. S., Spindler, B. D., Murphy, D. J., Hossain, M. M., Roca-Sabio, A., Platas‐Iglesias, C., Blas, A. D., et al. (2014) · Inorganic Chemistry · doi:10.1021/ic500244p · Cited by 101
Spectroscopic and computational investigation of actinium coordination chemistry
Ferrier, M. G., Batista, E. R., Berg, J. M., Birnbaum, E. R., Cross, J. N., Engle, J. W., Pierre, H. S. L., Kozimor, S. A., Lezama-Pacheco, J. S., Stein, B. W., et al. (2016) · Nature Communications · doi:10.1038/ncomms12312 · Cited by 99
Self-citationThe feasibility of 225 Ac as a source of ??-particles in radioimmunotherapy
Geerlings, M. W., Kaspersen, F. M., Apostolidis, C., & van der Hout, R. (1993) · Nuclear Medicine Communications · doi:10.1097/00006231-199302000-00009 · Cited by 95
Octadentate Picolinic Acid‐Based Bispidine Ligand for Radiometal Ions
Comba, P., Jermilova, U., Orvig, C., Patrick, B. O., Ramogida, C. F., Rück, K. S. L., Schneider, C., & Starke, M. (2017) · Chemistry - A European Journal · doi:10.1002/chem.201702284 · Cited by 94
Self-citationMaguire, W. F., McDevitt, M. R., Smith-Jones, P. M., & Scheinberg, D. A. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.138347 · Cited by 93
Dual-Target Binding Ligands with Modulated Pharmacokinetics for Endoradiotherapy of Prostate Cancer
Kelly, J. M., Amor‐Coarasa, A., Nikolopoulou, A., Wüstemann, T., Barelli, P. J., Kim, D., Williams, C. M., Zheng, X., Bi, C., Hu, B. X., et al. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.188722 · Cited by 87
Self-citationChappell, L. L., Deal, K. A., Dadachova, E., & Brechbiel, M. W. (2000) · Bioconjugate Chemistry · doi:10.1021/bc990153f · Cited by 82
Evaluation of 225 Ac for Vascular Targeted Radioimmunotherapy of Lung Tumors
Kennel, S. J., Chappell, L. L., Dadachova, K., Brechbiel, M. W., Lankford, T. K., Davis, I. A., Stabin, M. G., & Mirzadeh, S. (2000) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/108497800414329 · Cited by 82
Ferreirós‐Martínez, R., Esteban‐Gómez, D., Tóth, É., Blas, A. D., Platas‐Iglesias, C., & Rodríguez-Blas, T. (2011) · Inorganic Chemistry · doi:10.1021/ic200182e · Cited by 77
Essler, M., Gärtner, F. C., Neff, F., Blechert, B., Senekowitsch–Schmidtke, R., Bruchertseifer, F., Morgenstern, A., & Seidl, C. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-2023-6 · Cited by 76
Synthesis and Characterization of the Actinium Aquo Ion
Ferrier, M. G., Stein, B. W., Batista, E. R., Berg, J. M., Birnbaum, E. R., Engle, J. W., John, K. D., Kozimor, S. A., Lezama-Pacheco, J. S., & Redman, L. N. (2017) · ACS Central Science · doi:10.1021/acscentsci.6b00356 · Cited by 74
Clinical Pharmacology of Trastuzumab
Levêque, D., Gigou, L., & Bergerat, J. (2008) · Current Clinical Pharmacology · doi:10.2174/157488408783329931 · Cited by 61
Regueiro‐Figueroa, M., Barriada, J. L., Pallier, A., Esteban‐Gómez, D., Blas, A. D., Rodríguez-Blas, T., Tóth, É., & Platas‐Iglesias, C. (2015) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.5b00548 · Cited by 56
Treatment of Metastatic Bone Disease and the Emerging Role of Radium-223
Coleman, R. E. (2016) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2015.10.012 · Cited by 51
Kelly, J., Amor‐Coarasa, A., Nikolopoulou, A., Kim, D., Williams, C. M., Ponnala, S., & Babich, J. W. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3556-5 · Cited by 51
Self-citationFerreirós‐Martínez, R., Esteban‐Gómez, D., Blas, A. D., Platas‐Iglesias, C., & Rodríguez-Blas, T. (2009) · Inorganic Chemistry · doi:10.1021/ic901883h · Cited by 37
Comparison of the Biodistribution of 225Ac and Radio-Lanthanides as Citrate Complexes
Beyer, G. J., Bergmann, R., Schomäcker, K., Rösch, F., Schäfer, G., Kulikov, E. V., & Novgorodov, A. F. (1990) · Isotopenpraxis Isotopes in Environmental and Health Studies · doi:10.1080/10256019008624245 · Cited by 25
Cited by
Radioactive Main Group and Rare Earth Metals for Imaging and Therapy
Kostelnik, T. I., & Orvig, C. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00294 · Cited by 483
An Overview of Targeted Alpha Therapy with 225Actinium and 213Bismuth
Morgenstern, A., Apostolidis, C., Kratochwil, C., Sathekge, M., Krolicki, L., & Bruchertseifer, F. (2018) · Current Radiopharmaceuticals · doi:10.2174/1874471011666180502104524 · Cited by 370
Targeted alpha therapy: progress in radionuclide production, radiochemistry, and applications.
Nelson, B. J. B., Andersson, J. D., & Wuest, F. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics13010049 · Cited by 194
Development of targeted alpha particle therapy for solid tumors.
Tafreshi, N. K., Doligalski, M. L., Tichacek, C. J., Pandya, D. N., Budzevich, M. M., El-Haddad, G., Khushalani, N. I., Moros, E. G., McLaughlin, M. L., Wadas, T. J., et al. (2019) · Molecules · doi:10.3390/molecules24234314 · Cited by 157
Shi, M., Jakobsson, V., Greifenstein, L., Khong, P.-L., Chen, X., Baum, R. P., & Zhang, J. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1034315 · Cited by 68
Metadata
- Authors
- Thiele, N. A., Brown, V., Kelly, J. M., Amor‐Coarasa, A., Jermilova, U., MacMillan, S. N., Nikolopoulou, A., Ponnala, S., Ramogida, C. F., Robertson, A. K. H., Rodríguez‐Rodríguez, C., Schaffer, P., Williams, C., Babich, J. W., Radchenko, V., & Wilson, J. J.
- Venue
- Angewandte Chemie International Edition
- Publisher
- Wiley
- Published
- 2017-10-16
- Volume
- 56
- Issue
- 46
- Pages
- 14712-14717
- ISSN
- 1433-7851 (ISSN-L)
- 1521-3773
- OpenAlex
- W2757879990
- Cited by
- 288
- References
- 37
- FWCI
- 11.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.